Pharmacokinetics Study Of Rivaroxaban and Apixaban in Cancer Patients

NCT05819736 · clinicaltrials.gov ↗

UNKNOWN

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Anticoagulants and Thrombotic Disorders

Interventions

OTHER: Monitoring

Sponsor

Groupe Hospitalier Pitie-Salpetriere